Accepting New Clients! Immediate openings > book instantly through our website in bio! We understand that being stuck and feeling like everything you have tried has left you hopeless is one of the ...

Accepting New Clients NOW! Immediate openings! At Higher Sights Counseling we understand that being stuck and feeling like everything you have tried has left you hopeless is one of the most painful ...

SCIENCE LEADING TO JUST REMARKABLE MOMENTS. THIS TODDLER HAS NEVER BEEN ABLE TO HEAR HIS OWN NAME UNTIL NOW. IT’S ALL THANKS TO THE FIRST OF ITS KIND BILATERAL EAR GENE THERAPY FOR PEOPLE WHO WERE ...

Company shares preliminary results from Phase 1/2 clinical trial for patients with advanced Retinitis Pigmentosa (RP) NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Bionic Sight, Inc., a company ...

A university said it would conduct the world's largest clinical trial on a new therapy to treat some stroke survivors. Spatial inattention grasping therapy – known as SIGHT – uses balancing rods to ...

Sight has been restored to people who suffered blinding eye injuries using a new form of stem cell therapy. American surgeons ...

Back in January 2014, Digital Journal reported that, following a gene therapy trial, patients who were progressing toward blindness had considerably better vision after completing the treatment. The ...

Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...

Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through UCL Institute of Ophthalmology and Moorfields Eye Hospital, with ...

Opus Genetics has shared data on its gene therapy in children with an ultrarare eye disease, setting the biotech up to talk to the FDA about the next steps for the program. North Carolina-based Opus ...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene ...